ACM
KYMR icon

ADAR1 Capital Management’s Kymera Therapeutics KYMR Stock Holding History

ADAR1 Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,366
Closed -$583K – 246
2025
Q2 		$583K Buy
13,366
+3,366
+34% +$116K 0.09% 110
2025
Q1 		$274K Hold
10,000
– – 0.05% 131
2024
Q4 		$402K Sell
10,000
-1,856
-16% -$83.8K 0.08% 121
2024
Q3 		$561K Sell
11,856
-38,770
-77% -$1.71M 0.09% 108
2024
Q2 		$1.51M Buy
50,626
+34,626
+216% +$1.2M 0.3% 54
2024
Q1 		$643K Buy
+16,000
New +$572K 0.18% 73

Other funds holding KYMR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return